| KUROS BIOSCIENCES |
| Schweiz |
| Gesundheit |
| CH0325814116 / A2ALS5 |
| YTSN (Frankfurt) |
| FRA:YTSN, ETR:YTSN, YTSN:GR |
| - |
| https://kurosbio.com/ |
|
Kuros Biosciences AG is a Switzerland-based biotechnology company specializing in the discovery, development, and commercialization of innovative biologic technologies for bone healing and regeneration. Headquartered in Schlieren, with operations in ..
>Volltext.. |
| 797.06 Mio. EUR |
| 800.48 Mio. EUR |
| 148.1 Mio. EUR |
| 12.34 Mio. EUR |
| 7.6 Mio. EUR |
| 0.19 EUR |
| 11.75 Mio. EUR |
| 8.38 Mio. EUR |
| -0.31 Mio. EUR |
| 0.22 |
| 42.65% |
| - |
| - |
| - |
| - |
| - |
| KUROS |
| 07.09.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|